Main indications for peroral anticoagulants: how to choose an optimal drug

Abstract

Practical approaches to use of oral anticoagulants for prevention and treatment of thrombotic and thromboembolic complications in patients with atrial fibrillation, venous thromboembolism and coronary heart disease are considered. Comparison of main pharmacologic properties of DOACs and warfarin as well as their efficacy and safety in prospective randomized controlled trials are present. Clinical situations with minimal or no evidence for use of DOACs are specified.

Keywords

• пероральные антикоагулянты
• апиксабан
• дабигатрана этексилат
• ривароксабан
• варфарин
• peroral anticoagulants
• apixaban
• dabigatran
• rivaroxaban
• warfarin